Key result
Lower monocyte-to-HDL ratio is linked to ~3.5-fold higher repeat PCI risk in diabetic ACS.
Why the study?
The monocyte-to-high-density lipoprotein cholesterol ratio (MHR) has emerged as a novel biomarker of inflammation and oxidative stress, and its association with repeat revascularization after PCI in ACS patients with diabetes required evaluation.
Is the monocyte-to-high-density lipoprotein cholesterol ratio (MHR) associated with the risk of clinically driven repeat revascularization after PCI in patients with acute coronary syndrome and type 2 diabetes mellitus?
Cohort (n=896)
No
Is the monocyte-to-high-density lipoprotein cholesterol ratio (MHR) associated with the risk of clinically driven repeat revascularization after PCI in patients with acute coronary syndrome and type 2 diabetes mellitus?
In patients with ACS and type 2 diabetes undergoing PCI with drug-eluting stents, an elevated monocyte-to-HDL-C ratio (MHR) is independently and nonlinearly associated with a higher risk of repeat revascularization up to an exploratory threshold of 0.613.
Answers are grounded in this paper and cite their sources.
Supports MHR as a potential repeat PCI risk marker in diabetic ACS; hypothesis-generating and requires prospective validation before clinical use.
Purpose: The monocyte-to-high-density lipoprotein cholesterol ratio (MHR) has emerged as a novel biomarker reflecting inflammation and oxidative stress. This study aimed to evaluate the association between MHR and the risk of repeat revascularization after percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS) patients with diabetes. Methods: In this single-centre retrospective cohort study, 896 patients with acute coronary syndrome and diabetes mellitus who underwent PCI between January 2013 and October 2023 and returned for a second coronary angiography were included. The data were extracted from the hospital’s electronic medical record (EMR) system and the Picture Archiving and Communication System (PACS). Cox regression with extensive adjustment, Kaplan-Meier curve, restricted cubic splines (RCS), and piecewise regression models were used to assess the independent predictive value and potential nonlinear relationship. Results: During a median follow-up of 28.5 months, 487 patients (54.4%) underwent repeat revascularization. Restricted cubic spline analysis revealed a significant nonlinear relationship between MHR and the risk of repeat revascularization (P for nonlinearity = 0.001). Piecewise Cox regression identified an inflection point at an MHR of 0.613. Below this threshold, MHR was positively associated with the risk (Hazard Ratio [HR] = 3.55, 95% Confidence Interval [CI]: 1.73 to 7.27, P < 0.001). Above this threshold, however, the association was not statistically significant (HR = 0.80, P = 0.411). Conclusion: MHR is independently associated with repeat revascularization after PCI in patients with ACS and diabetes, and their relationship is nonlinear. This metric is identified an exploratory inflection point at an MHR of 0.613, which was unstable under resampling and requires external validation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Acute coronary syndrome (ACS) with type 2 diabetes mellitus undergoing percutaneous coronary intervention (PCI) (n=896). Monocyte-to-high-density lipoprotein cholesterol ratio (MHR) vs. Lowest MHR quartile (Q1: <0.283) or MHR across continuous threshold (<0.613 vs >=0.613) was evaluated on Clinically driven repeat revascularization (repeat PCI) (HR 3.55, 95% CI 1.73 to 7.27, p=<0.001). Monocyte-to-HDL cholesterol ratio below 0.613 was positively associated with clinically driven repeat PCI in diabetic ACS patients.
Synapse has enriched 10 related papers. Consider them for comparative context: